#4 - Cardinal Health (NYSE:CAH)
Health care will always be a strong sector, particularly if you’re a pharmaceutical distributor. The ability to help individuals manage chronic conditions transcends political ideology. And that’s one reason why Cardinal Health (NYSE:CAH) makes this list.
CAH stock struggled in 2020 due to its being named in a lawsuit brought by states that named Cardinal Health as a defendant for its role in the opioid epidemic. However, in late 2020, Cardinal Health along with other drug wholesalers reached a $26 billion settlement. That should decrease the uncertainty on the company’s balance sheet.
And this allows investors to focus on the company’s fundamentals. With a P/E ratio of just over 10, CAH stock is trading at a level that is significantly lower than where it was just a few years ago. And the company pays out a solid dividend that has a yield of 3.77%.
Cardinal has increased its dividend for the last 34 years and has a comfortable payout ratio of 24.28%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More - Current Price
- $117.97
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 8 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $127.50 (8.1% Upside)
